Zobrazeno 1 - 10
of 1 079
pro vyhledávání: '"Anemia, Diamond-Blackfan"'
Autor:
Wilkes MC; Division of Hematology/Oncology, Department of Pediatrics, Stanford University, Stanford, California, USA; Kabara Cancer Research Institute, Gundersen Medical Foundation, La Crosse, Wisconsin, USA. Electronic address: mwilkes@stanford.edu., Shibuya A; Division of Hematology/Oncology, Department of Pediatrics, Stanford University, Stanford, California, USA., Liu YL; Division of Hematology/Oncology, Department of Pediatrics, Stanford University, Stanford, California, USA., Mark K; Division of Hematology/Oncology, Department of Pediatrics, Stanford University, Stanford, California, USA., Mercado J; Division of Hematology/Oncology, Department of Pediatrics, Stanford University, Stanford, California, USA., Saxena M; Division of Hematology/Oncology, Department of Pediatrics, Stanford University, Stanford, California, USA., Sathianathen RS; Division of Hematology/Oncology, Department of Pediatrics, Stanford University, Stanford, California, USA., Kim HN; Division of Hematology/Oncology, Department of Pediatrics, Stanford University, Stanford, California, USA., Glader B; Division of Hematology/Oncology, Department of Pediatrics, Stanford University, Stanford, California, USA., Kenny P; Kabara Cancer Research Institute, Gundersen Medical Foundation, La Crosse, Wisconsin, USA., Sakamoto KM; Division of Hematology/Oncology, Department of Pediatrics, Stanford University, Stanford, California, USA.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2024 Aug; Vol. 300 (8), pp. 107542. Date of Electronic Publication: 2024 Jul 09.
Autor:
Iskander D; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London, United Kingdom; Department of Paediatric Haematology, St Mary's Hospital, Imperial College Healthcare Trust, London, United Kingdom. Electronic address: d.iskander@imperial.ac.uk., Karadimitris A; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London, United Kingdom., Roberts I; MRC Molecular Haematology Unit, WIMM, University of Oxford, Oxford, United Kingdom; Department of Paediatrics, Children's Hospital and MHU, WIMM, Oxford University and John Radcliffe Hospital, Oxford, United Kingdom.
Publikováno v:
Experimental hematology [Exp Hematol] 2024 Jul; Vol. 135, pp. 104235. Date of Electronic Publication: 2024 May 11.
Autor:
Osuna MAL; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, Unites States., Han L; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, Unites States. Electronic address: lei.han@stjude.org., Connelly JP; Center for Advanced Genome Engineering, St. Jude Children's Research Hospital, Memphis, TN 38105, Unites States., Miller-Preutt S; Center for Advanced Genome Engineering, St. Jude Children's Research Hospital, Memphis, TN 38105, Unites States., Weiss MJ; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, Unites States., Wlodarski MW; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, Unites States. Electronic address: marcin.wlodarski@stjude.org., Bhoopalan SV; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, Unites States. Electronic address: senthil.bhoopalan@stjude.org.
Publikováno v:
Stem cell research [Stem Cell Res] 2024 Sep; Vol. 79, pp. 103479. Date of Electronic Publication: 2024 Jun 19.
Autor:
Vale M; Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i, 252 50 Vestec, Czech Republic., Prochazka J; Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i, 252 50 Vestec, Czech Republic.; Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i, 252 50 Vestec, Czech Republic., Sedlacek R; Laboratory of Transgenic Models of Diseases, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i, 252 50 Vestec, Czech Republic.; Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, v.v.i, 252 50 Vestec, Czech Republic.
Publikováno v:
Cells [Cells] 2024 May 27; Vol. 13 (11). Date of Electronic Publication: 2024 May 27.
Autor:
Giménez Y; Division of Hematopoietic Innovative Therapies, CIEMAT, Madrid, Spain.; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Advanced Therapies Unit, IIS-Fundación Jimenez Diaz (IIS-FJD, UAM), Madrid, Spain., Palacios M; Division of Hematopoietic Innovative Therapies, CIEMAT, Madrid, Spain.; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Advanced Therapies Unit, IIS-Fundación Jimenez Diaz (IIS-FJD, UAM), Madrid, Spain., Sánchez-Domínguez R; Division of Hematopoietic Innovative Therapies, CIEMAT, Madrid, Spain.; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Advanced Therapies Unit, IIS-Fundación Jimenez Diaz (IIS-FJD, UAM), Madrid, Spain., Zorbas C; RNA Molecular Biology, Fonds de la Recherche Scientifique (FRS/FNRS), Université libre de Bruxelles (ULB), Biopark campus, Gosselies, Belgium., Peral J; Division of Hematopoietic Innovative Therapies, CIEMAT, Madrid, Spain.; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Advanced Therapies Unit, IIS-Fundación Jimenez Diaz (IIS-FJD, UAM), Madrid, Spain., Puzik A; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Ugalde L; Division of Hematopoietic Innovative Therapies, CIEMAT, Madrid, Spain.; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Advanced Therapies Unit, IIS-Fundación Jimenez Diaz (IIS-FJD, UAM), Madrid, Spain., Alberquilla O; Division of Hematopoietic Innovative Therapies, CIEMAT, Madrid, Spain.; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Advanced Therapies Unit, IIS-Fundación Jimenez Diaz (IIS-FJD, UAM), Madrid, Spain., Villanueva M; Division of Hematopoietic Innovative Therapies, CIEMAT, Madrid, Spain.; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Advanced Therapies Unit, IIS-Fundación Jimenez Diaz (IIS-FJD, UAM), Madrid, Spain., Río P; Division of Hematopoietic Innovative Therapies, CIEMAT, Madrid, Spain.; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Advanced Therapies Unit, IIS-Fundación Jimenez Diaz (IIS-FJD, UAM), Madrid, Spain., Gálvez E; Hospital del Niño Jesús, Madrid, Spain., Da Costa L; AP-HP, Hematology diagnostic laboratory, Hôpital Robert-Debré, Paris, France.; University of Paris; Hematim, UR4666, UPJV; LABEX GR-EX, Paris, France., Strullu M; AP-HP, service Immuno-Hématologie pédiatique, Hôpital R. Debré, Paris, France., Catala A; Hospital San Joan D'Deu, Barcelona, Spain., Ruiz-Llobet A; Hospital San Joan D'Deu, Barcelona, Spain., Segovia JC; Division of Hematopoietic Innovative Therapies, CIEMAT, Madrid, Spain.; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Advanced Therapies Unit, IIS-Fundación Jimenez Diaz (IIS-FJD, UAM), Madrid, Spain., Sevilla J; Hospital del Niño Jesús, Madrid, Spain., Strahm B; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Niemeyer CM; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Beléndez C; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Sección de Hematología y Oncología Pediátricas, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain., Leblanc T; AP-HP, service Immuno-Hématologie pédiatique, Hôpital R. Debré, Paris, France., Lafontaine DL; RNA Molecular Biology, Fonds de la Recherche Scientifique (FRS/FNRS), Université libre de Bruxelles (ULB), Biopark campus, Gosselies, Belgium., Bueren J; Division of Hematopoietic Innovative Therapies, CIEMAT, Madrid, Spain.; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Advanced Therapies Unit, IIS-Fundación Jimenez Diaz (IIS-FJD, UAM), Madrid, Spain., Navarro S; Division of Hematopoietic Innovative Therapies, CIEMAT, Madrid, Spain.; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Advanced Therapies Unit, IIS-Fundación Jimenez Diaz (IIS-FJD, UAM), Madrid, Spain.
Publikováno v:
JCI insight [JCI Insight] 2024 May 22; Vol. 9 (10). Date of Electronic Publication: 2024 May 22.
Autor:
Wlodarski MW; Department of Hematology, St Jude Children's Research Hospital, Memphis, TN, USA; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Electronic address: marcin.wlodarski@stjude.org., Vlachos A; Cohen Children's Medical Center, Hematology/Oncology and Stem Cell Transplantation, Hew Hyde Park, NY, USA; Feinstein Institutes for Medical Research, Manhasset, NY, USA; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA., Farrar JE; Arkansas Children's Research Institute and Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Da Costa LM; Hôpital R. DEBRE, Groupe Hospitalier Universitaire, Assistance Publique-Hôpitaux de Paris Nord, Université de Paris Cité, Paris, France; HEMATIM, EA4666, UPJV, Amiens, France; Le LabEx Gr-Ex - Biogénèse et Pathologies du Globule Rouge, Paris, France., Kattamis A; First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece., Dianzani I; Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy., Belendez C; Pediatric Hematology and Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain; Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain; Instituto Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Unal S; Hacettepe University, Department of Pediatric Hematology and Research Center for Fanconi Anemia and Other Inherited Bone Marrow Failure Syndromes, Ankara, Turkey., Tamary H; The Rina Zaizov Hematology-Oncology Division, Schneider Children's Medical Center of Israel, Peta Tikvah, Israel; Felsenstein Medical Research Center, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel., Pasauliene R; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Pospisilova D; Department of Pediatrics, Faculty Hospital of Palacky University, Olomouc, Czech Republic., de la Fuente J; Department of Paediatrics, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK; Department of Immunology and Inflammation, Imperial College London, London, UK., Iskander D; Department of Paediatrics, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK; Department of Immunology and Inflammation, Imperial College London, London, UK., Wolfe L; Cohen Children's Medical Center, Hematology/Oncology and Stem Cell Transplantation, Hew Hyde Park, NY, USA; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA., Liu JM; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA., Shimamura A; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Albrecht K; Department of Oncology, Paediatric Haematology, Clinical Transplantology and Paediatrics, Medical University of Warsaw, Warsaw, Poland., Lausen B; Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Bechensteen AG; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway., Tedgard U; Department of Pediatric Hematology and Oncology, Skåne University Hospital, Lund, Sweden., Puzik A; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Quarello P; Department of Pediatric and Public Health Sciences, University of Turin, Turin, Italy., Ramenghi U; Department of Pediatric and Public Health Sciences, University of Turin, Turin, Italy., Bartels M; Pediatric Hematology Department, University Medical Center Utrecht, Utrecht, Netherlands., Hengartner H; Pediatric Hospital of Eastern Switzerland St Gallen, St Gallen, Switzerland., Farah RA; Department of Pediatrics, LAU Medical Center-Rizk Hospital, Beirut, Lebanon., Al Saleh M; King Faisal Hospital and Research Center Riyadh, Riyadh, Saudi Arabia., Hamidieh AA; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Yang W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China., Ito E; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Kook H; Chonnam National University Hwasun Hospital, Gwangju, South Korea., Ovsyannikova G; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Kager L; St. Anna Children's Hospital, Department of Pediatrics, Medical University Vienna, Vienna, Austria; Children's Cancer Research Institute, Vienna, Austria., Gleizes PE; MCD, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UT3, Toulouse, France., Dalle JH; Pediatric Immunology and Hematology Department and CRMR aplasies médullaires, Robert Debré Hospital, Groupe Hospitalier Universitaire, Assistance Publique-Hôpitaux de Paris Nord, Université de Paris Cité, Paris, France., Strahm B; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Niemeyer CM; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium, Freiburg, Germany; German Cancer Research Center, Heidelberg, Germany., Lipton JM; Cohen Children's Medical Center, Hematology/Oncology and Stem Cell Transplantation, Hew Hyde Park, NY, USA; Feinstein Institutes for Medical Research, Manhasset, NY, USA; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA., Leblanc TM; Pediatric Immunology and Hematology Department and CRMR aplasies médullaires, Robert Debré Hospital, Groupe Hospitalier Universitaire, Assistance Publique-Hôpitaux de Paris Nord, Université de Paris Cité, Paris, France.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 May; Vol. 11 (5), pp. e368-e382.
Autor:
Lipton JM; Division of Hematology Oncology Stem Cell Transplant/Cellular Therapy, Cohen Children's Medical Center, Northwell Health, New Hyde Park, New York, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 May; Vol. 204 (5), pp. 1598-1599. Date of Electronic Publication: 2024 Mar 14.
Autor:
Duncan BB; Translational Stem Cell Biology Branch, NHLBI, Bethesda, Maryland, USA., Lotter JL; Office of the Clinical Director, NHLBI, Bethesda, Maryland, USA., Superata J; Office of the Clinical Director, NHLBI, Bethesda, Maryland, USA., Barranta ME; Office of the Clinical Director, NHLBI, Bethesda, Maryland, USA., Machado T; Office of the Clinical Director, NHLBI, Bethesda, Maryland, USA., Darden I; Office of the Clinical Director, NHLBI, Bethesda, Maryland, USA., Venugopal S; Office of the Clinical Director, NHLBI, Bethesda, Maryland, USA., Wu CO; Office of Biostatistics Research, NHLBI, Bethesda, Maryland, USA., Abkowitz JL; Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington, USA., Dunbar CE; Translational Stem Cell Biology Branch, NHLBI, Bethesda, Maryland, USA., Young DJ; Translational Stem Cell Biology Branch, NHLBI, Bethesda, Maryland, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 May; Vol. 204 (5), pp. 2077-2085. Date of Electronic Publication: 2024 Mar 10.
Autor:
Da Costa L; Service d'Hématologie Biologique (Hematology Diagnostic Lab), AP-HP, Hôpital Bicêtre, F-94270 Le Kremlin-Bicêtre, France; University of Paris Saclay, F-94270 Le Kremlin-Bicêtre, France; University of Paris Cité, F-75010 Paris, France; University of Picardie Jules Verne, F-80000 Amiens, France; Inserm U1170, IGR, F-94805 Villejuif/HEMATIM UR4666, F-80000 Amiens, France; Laboratory of Excellence for Red Cells, LABEX GR-Ex, F-75015 Paris, France. Electronic address: lydie.dacosta@aphp.fr., Mohandas N; New York Blood Center, NY, USA., David-NGuyen L; Service d'Hématologie Biologique (Hematology Diagnostic Lab), AP-HP, Hôpital Bicêtre, F-94270 Le Kremlin-Bicêtre, France., Platon J; Inserm U1170, IGR, F-94805 Villejuif/HEMATIM UR4666, F-80000 Amiens, France., Marie I; Service d'Hématologie Biologique (Hematology Diagnostic Lab), AP-HP, Hôpital Bicêtre, F-94270 Le Kremlin-Bicêtre, France., O'Donohue MF; Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France., Leblanc T; Service d'immuno-hématologie pédiatrique, Hôpital Robert-Debré, F-75019 Paris, France., Gleizes PE; Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.
Publikováno v:
Blood cells, molecules & diseases [Blood Cells Mol Dis] 2024 May; Vol. 106, pp. 102838. Date of Electronic Publication: 2024 Feb 17.
Autor:
Gunnes MW; Barne- og ungdomsklinikken, Haukeland universitetssjukehus, og, Barneavdeling for kreft- og blodsykdommer, Oslo universitetssykehus, Rikshospitalet., Benneche A; Avdeling for medisinsk genetikk, Haukeland universitetssjukehus., Bechensteen AG; Barneavdeling for kreft- og blodsykdommer, Oslo universitetssykehus, Rikshospitalet.
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2024 Mar 15; Vol. 144 (4). Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).